These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9106989)

  • 21. Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation.
    Ingargiola M; Dittfeld C; Runge R; Zenker M; Heldt JM; Steinbach J; Cordes N; Baumann M; Kotzerke J; Kunz-Schughart LA
    Cytometry A; 2012 Oct; 81(10):865-73. PubMed ID: 22930585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of DOTA-conjugated antibody fragments for radioimmunoimaging.
    Smith-Jones PM; Solit DB
    Methods Enzymol; 2004; 386():262-75. PubMed ID: 15120256
    [No Abstract]   [Full Text] [Related]  

  • 23. Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent.
    Blend MJ; Stastny JJ; Swanson SM; Brechbiel MW
    Cancer Biother Radiopharm; 2003 Jun; 18(3):355-63. PubMed ID: 12954122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of Holmium-166 Labelled Macroaggregates for radionuclide synovectomy.
    Kropácek M; Melichar F; Henková K; Konopková M
    Nucl Med Rev Cent East Eur; 2003; 6(1):1-4. PubMed ID: 14600925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo evaluation of bismuth-labeled monoclonal antibody comparing DTPA-derived bifunctional chelates.
    Milenic DE; Roselli M; Mirzadeh S; Pippin CG; Gansow OA; Colcher D; Brechbiel MW; Schlom J
    Cancer Biother Radiopharm; 2001 Apr; 16(2):133-46. PubMed ID: 11385960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated radiolabelling of monoclonal antibodies with the Modular Lab system.
    Ellison D; Kaufman J; Mather SJ
    Nucl Med Commun; 2010 Feb; 31(2):173-7. PubMed ID: 19952855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.
    Vrouenraets MB; Visser GW; Loup C; Meunier B; Stigter M; Oppelaar H; Stewart FA; Snow GB; van Dongen GA
    Int J Cancer; 2000 Oct; 88(1):108-14. PubMed ID: 10962447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of Site-Specific Radiolabeled Antibodies for Radioimmunotherapy via Genetic Code Expansion.
    Wu Y; Zhu H; Zhang B; Liu F; Chen J; Wang Y; Wang Y; Zhang Z; Wu L; Si L; Xu H; Yao T; Xiao S; Xia Q; Zhang L; Yang Z; Zhou D
    Bioconjug Chem; 2016 Oct; 27(10):2460-2468. PubMed ID: 27617674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of inorganic radioactive holmium-166 microspheres for internal radionuclide therapy.
    Arranja AG; Hennink WE; Chassagne C; Denkova AG; Nijsen JFW
    Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110244. PubMed ID: 31753348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of methods for large scale preparation of antibody ligand conjugates.
    Wu C; Gansow OA; Brechbiel MW
    Nucl Med Biol; 1999 Apr; 26(3):339-42. PubMed ID: 10363806
    [No Abstract]   [Full Text] [Related]  

  • 31. Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice.
    Suzuki YS; Momose Y; Higashi N; Shigematsu A; Park KB; Kim YM; Kim JR; Ryu JM
    J Nucl Med; 1998 Dec; 39(12):2161-6. PubMed ID: 9867162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scaling-down antibody radiolabeling reactions with zirconium-89.
    Knight JC; Paisey SJ; Dabkowski AM; Marculescu C; Williams AS; Marshall C; Cornelissen B
    Dalton Trans; 2016 Apr; 45(15):6343-7. PubMed ID: 26986633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of alpha-emitting 213Bi-labeled antibody constructs for clinical use.
    McDevitt MR; Finn RD; Ma D; Larson SM; Scheinberg DA
    J Nucl Med; 1999 Oct; 40(10):1722-7. PubMed ID: 10520715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
    Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
    Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy.
    Uccelli L; Martini P; Pasquali M; Boschi A
    Biomed Res Int; 2017; 2017():5923609. PubMed ID: 28951872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
    Griffiths GL; Govindan SV; Sharkey RM; Fisher DR; Goldenberg DM
    J Nucl Med; 2003 Jan; 44(1):77-84. PubMed ID: 12515879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer.
    Das T; Chakraborty S; Sarma HD; Venkatesh M; Banerjee S
    Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (I). Conjugation, labeling, immunoreactivity and in vitro stability].
    Sun B
    Kaku Igaku; 1994 May; 31(5):459-71. PubMed ID: 8028218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation of 188Re-RC-160 somatostatin analog: a peptide for local/regional radiotherapy.
    Zamora PO; Marek MJ; Knapp FF
    Appl Radiat Isot; 1997 Mar; 48(3):305-9. PubMed ID: 9116651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new measurement of the half-life of (166m)Ho.
    Nedjadi Y; Bailat C; Caffari Y; Froidevaux P; Wastiel C; Kivel N; Guenther-Leopold I; Triscone G; Jaquenod F; Bochud F
    Appl Radiat Isot; 2012 Sep; 70(9):1990-6. PubMed ID: 22421399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.